In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis.
Visceral leishmaniasis (VL) is characterized by expansion of myeloid cells in the liver and spleen, which leads to a severe splenomegaly associated with higher risk of mortality. This increased cellularity is thought to be a consequence of recruitment of cells to the viscera. We studied whether the...
Main Authors: | E Yaneth Osorio, Audrie A Medina-Colorado, Bruno L Travi, Peter C Melby |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0242337 |
Similar Items
-
Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis.
by: E Yaneth Osorio, et al.
Published: (2014-06-01) -
Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
by: Audrie A Medina-Colorado, et al.
Published: (2017-01-01) -
Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
by: Yaneth Osorio, et al.
Published: (2011-01-01) -
Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
by: E Yaneth Osorio, et al.
Published: (2012-01-01) -
Disorganization of spleen compartments and dermatitis in canine visceral leishmaniasis
by: Claudia C. Santana, et al.
Published: (2019-05-01)